Dr. Montano-Loza on Link Between HCC Risk and High Visceral Adipose Tissue

Aldo J. Montano-Loza, MD, MSc, PhD
Published: Monday, Nov 14, 2016


Aldo J. Montano-Loza, MD, MSc, PhD, associate professor of medicine, program director of hepatology, gastroenterology rotation supervisor, University of Alberta, discusses the link between high visceral adipose tissue and hepatocellular carcinoma risk in patients with cirrhosis.
 
In his study, Montano-Loza determined that male patients with cirrhosis and liver cancer had a higher visceral adipose tissue compared to those who did not have liver cancer. Patients that underwent a liver transplant due to liver cancer and then relapsed, were also found to have higher concentration of visceral adipose tissue than those who did not have recurrence after a liver transplant. 

These findings suggest that high visceral adipose tissue is associated with a higher risk of liver cancer before and after liver transplant for patients with cirrhosis.
 

Aldo J. Montano-Loza, MD, MSc, PhD, associate professor of medicine, program director of hepatology, gastroenterology rotation supervisor, University of Alberta, discusses the link between high visceral adipose tissue and hepatocellular carcinoma risk in patients with cirrhosis.
 
In his study, Montano-Loza determined that male patients with cirrhosis and liver cancer had a higher visceral adipose tissue compared to those who did not have liver cancer. Patients that underwent a liver transplant due to liver cancer and then relapsed, were also found to have higher concentration of visceral adipose tissue than those who did not have recurrence after a liver transplant. 

These findings suggest that high visceral adipose tissue is associated with a higher risk of liver cancer before and after liver transplant for patients with cirrhosis.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x